Logo Image
Opinion|Videos|January 28, 2025

Streamlining Transitions Between Academic and Community Centers

Jeffrey V. Matous, MD, discusses how telehealth and remote monitoring can enhance the safe administration of bispecific antibody therapies in community settings, especially for rural or underserved populations, while emphasizing the importance of communication and collaboration between academic and community practices to improve delivery and coordination of care.

Episodes in this series

Video content above is prompted by the following:

  • How can telehealth and remote monitoring, including tools for managing CRS or other toxicities, support the safe administration of bispecific antibody therapies in community settings while expanding access for rural or underserved populations?
  • How can academic and community practices strengthen communication and collaboration to support the delivery of bispecific antibody therapies, and what tools or frameworks might facilitate this coordination?

Related Content